Renaissance Capital logo

CRNX News

US IPO Weekly Recap: Bud, biotechs, banks and breast implants make gains in 9-IPO week

ALLK

The IPO market came back full force this week following the July 4th pause. Nine deals raised a combined $931 million, averaging a gain of 29%. Five biotechs went public, including top performer Allakos, which finished the week up 95%. Tilray grabbed...read more

Rare endocrine disease biotech Crinetics Pharmaceuticals prices upsized IPO at $17 high end

Crinetics Pharmaceuticals logo

Crinetics Pharmaceuticals, a clinical stage biotech developing oral therapies for rare endocrine diseases, raised $102 million by offering 6 million shares at $17, the high end of the $15 to $17 range. The company had originally planned to raise $80 million by...read more

US IPO Week Ahead: 10 US IPOs planned for the week of July 16

USIPOCalendar

There are 10 IPOs expected to price this week after the July holiday slowdown. The week is being led by oil and gas OEM AFG Holdings and Canadian cannabis supplier Tilray. Six...read more

The IPO market has resumed being on fire with 11 new deals

Crinetics Pharmaceuticals logo

After a short holiday break, the IPO market has resumed being on fire. 11 deals launched their offerings. 10 are on the calendar for next week, including 7 that plan to...read more